Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. [electronic resource]
Producer: 20150120Description: 459-65 p. digitalISSN:- 1600-6143
- Adult
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antiphospholipid Syndrome -- etiology
- Complement Inactivating Agents -- therapeutic use
- Follow-Up Studies
- Graft Rejection -- etiology
- Humans
- Kidney Failure, Chronic -- complications
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Postoperative Complications -- prevention & control
- Prognosis
- Prospective Studies
- Recurrence
- Remission Induction
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.